Opus Three is a Life Sciences Consulting Firm focused on scientific and clinical strategies for drug and diagnostic development with an emphasis on personalized medicine.
Our experience in regulatory requirements and our understanding of payers’ needs allows us to provide a unique mix of services that integrate scientific and clinical needs with regulatory and reimbursement considerations into actionable, real-world based product development and commercialization strategies.
We work with clients in a hands-on fashion and support them from early strategic planning through clinical research and development to regulatory submissions and appropriate reimbursement approaches of their products.
Opus Three's clients include big and small pharmaceutical companies, device and diagnostic companies, laboratories, bioinformatic and health IT companies, as well as venture firms and private equity financial institutions. We serve the private, public, and academic sectors.
Our services include: